Dry eye

3 trials MedDRA PT
3 Registered trials
0 Recruiting
3 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
S Ophthalmology/ENT (ATC S) 1
Mechanism of action (INN-stem analysis)
Erythropoietin analogue 1 substance
Corticosteroid 1 substance
Unknown / small molecule 1 substance
Phase II: 2 Phase IV: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase II

2 trials
  • Dompe' Farmaceutici S.p.A. Commercial
    CENEGERMIN
    2023-507561-26-00 1 country 2024 n=126
    Ended
  • Fundacion De Investigacion Biomedica De Salamanca Academic
    ALLOGENEIC ADIPOSE-DERIVED ADULT MESENCHYMAL STEM CELLS EXPANDED
    2024-519772-10-00 1 country n=30
    Pending

Phase IV

1 trial
  • Laboratorios Lesvi S.L. Commercial
    HYDROCORTISONE SODIUM PHOSPHATE
    2024-518093-13-00 1 country 2021 n=54
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Dompe' Farmaceutici S.p.A. Commercial 1 Phase II 0
Laboratorios Lesvi S.L. Commercial 1 Phase IV 0
Fundacion De Investigacion Biomedica De Salamanca Academic 1 Phase II 0
New trials by year
2021
1
2024
1
← All indication landscapes